More tax exemptions set for R&D spending

Published: 2010-01-25 06:57:00

Updated: 2010-01-25 06:57:00

Korea seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the era of free trade agreements (FTAs).

The government plans to redouble efforts to use patents that have not been u...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK